We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
Cap. Flow
+$6.41B
Cap. Flow %
5.41%
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309

Sector Composition

Rank Sector Weight
1 Healthcare 11.59%
2 Technology 10.75%
3 Financials 9.31%
4 Consumer Discretionary 6.45%
5 Communication Services 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VWO icon
1076
PUT
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$15.1M 0.01%
374,700
-63,800
-15% -$2.63M
LDOS icon
1077
Leidos
LDOS
$14.5B
$15M 0.01%
174,820
-216,073
-55% -$18.1M
PVH icon
1078
PVH
PVH
$4B
$15M 0.01%
169,495
-4,170
-2% -$348K
ERIC icon
1079
Ericsson
ERIC
$32.2B
$14.9M 0.01%
1,871,474
+1,821,680
+3,658% +$15.5M
SMH icon
1080
VanEck Semiconductor ETF
SMH
$65.2B
$14.9M 0.01%
250,422
+19,880
+9% +$1.15M
ARW icon
1081
Arrow Electronics
ARW
$11.1B
$14.9M 0.01%
199,855
+52,917
+36% +$3.74M
CBB
1082
DELISTED
Cincinnati Bell Inc.
CBB
$14.9M 0.01%
2,932,808
-1,842
-0.1% -$9.02K
VAR
1083
DELISTED
Varian Medical Systems, Inc.
VAR
$14.8M 0.01%
124,606
-6,003
-5% -$714K
VST icon
1084
Vistra
VST
$50B
$14.8M 0.01%
553,853
-353,102
-39% -$8.4M
FMX icon
1085
Fomento Económico Mexicano
FMX
$43.6B
$14.8M 0.01%
161,203
-23,028
-12% -$2.12M
BIIB icon
1086
CALL
Biogen
BIIB
$30B
$14.8M 0.01%
63,400
+5,900
+10% +$1.37M
FRC
1087
DELISTED
First Republic Bank
FRC
$14.7M 0.01%
152,190
-235,688
-61% -$22.3M
AIV
1088
Aimco
AIV
$387M
$14.7M 0.01%
2,118,465
-523,375
-20% -$3.54M
APA icon
1089
PUT
APA Corp
APA
$13.2B
$14.7M 0.01%
574,500
+499,500
+666% +$12M
OGE icon
1090
OGE Energy
OGE
$9.78B
$14.7M 0.01%
323,443
+51,487
+19% +$2.23M
ETFC
1091
DELISTED
E*Trade Financial Corporation
ETFC
$14.7M 0.01%
335,924
+58,450
+21% +$2.59M
SIX
1092
DELISTED
Six Flags Entertainment Corp.
SIX
$14.7M 0.01%
288,624
-53,318
-16% -$2.89M
GS icon
1093
PUT
Goldman Sachs
GS
$300B
$14.7M 0.01%
70,700
-78,000
-52% -$16.3M
JLL icon
1094
Jones Lang LaSalle
JLL
$16.3B
$14.6M 0.01%
105,246
-817
-0.8% -$113K
GRUB
1095
CALL
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$14.6M 0.01%
129,700
+107,500
+484% +$14.3M
NKE icon
1096
PUT
Nike
NKE
$61.9B
$14.6M 0.01%
155,200
+4,700
+3% +$403K
GL icon
1097
Globe Life
GL
$14.2B
$14.5M 0.01%
151,889
-9,798
-6% -$889K
J icon
1098
Jacobs Solutions
J
$15.9B
$14.5M 0.01%
191,837
+29,313
+18% +$2.1M
NRG icon
1099
NRG Energy
NRG
$28.3B
$14.5M 0.01%
366,601
-37,801
-9% -$1.37M
NKTR icon
1100
Nektar Therapeutics
NKTR
$2.39B
$14.5M 0.01%
53,061
+15,043
+40% +$5.52M

Similar funds

Credit Suisse's Q3 2019 Portfolio in Review

As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.

  • Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
  • Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
  • Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
  • Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
  • Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
  • Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
  • Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.